Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
Joseph GLIGOROV
Oncologist, Paris, France
Oncologist, Paris, France
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Willy VANGU
Nuclear Medicine, Johannesburg, South Africa
Rita SAKR
Breast Oncoplastic Surgeon & Ob-Gynecologist
Dubai, UEA
Copyright © 2026 - BCU